OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,160,097 | +247.4% | 93,935 | +154.0% | 0.00% | – |
| Q2 2023 | $333,974 | +135.3% | 36,985 | -9.6% | 0.00% | – |
| Q1 2023 | $141,906 | +81.0% | 40,895 | +27.8% | 0.00% | – |
| Q4 2022 | $78,383 | -85.0% | 31,993 | -83.1% | 0.00% | – |
| Q3 2022 | $522,000 | -37.5% | 189,009 | -7.9% | 0.00% | – |
| Q2 2022 | $835,000 | -56.0% | 205,297 | -54.0% | 0.00% | – |
| Q1 2022 | $1,899,000 | -6.7% | 445,948 | +104.9% | 0.00% | – |
| Q4 2021 | $2,036,000 | -51.0% | 217,600 | +44.5% | 0.00% | -100.0% |
| Q3 2021 | $4,151,000 | +202.1% | 150,619 | +206.7% | 0.00% | – |
| Q2 2021 | $1,374,000 | +96.3% | 49,112 | +132.7% | 0.00% | – |
| Q1 2021 | $700,000 | -73.6% | 21,101 | -61.7% | 0.00% | -100.0% |
| Q4 2020 | $2,652,000 | – | 55,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |